The content on this site is intended for healthcare professionals only
The results of the global obstacles to lung cancer screening report
Professor Rudolf Huber - The Hospital of the University of Munich, Munich, Germ...
11 Aug 2022
IASLC Early Detection and Screening Committee to report on global obstacles to l...
Dr Milena Cavic - Institute for Oncology and Radiology of Serbia, Belgrade, Serb...
11 Aug 2022
YESS: Personalised smoking cessation support in a lung cancer screening program
Dr Rachael Murray - The University of Nottingham, Nottingham, UK
11 Aug 2022
The necessary early diagnosis needed for young adults with LC vs. older adults
Alexandra Potter - Massachusetts General Hospital, Boston, USA
11 Aug 2022
New patient-centric addendum received positive results
Dr Upal Basu Roy - Vice President of Research, LUNGevity Foundation, Chicago, US...
11 Aug 2022
Initial steps in creating a patient-centric addendum to clinical trial informed ...
Dr Belinda King-Kallimanis - Director of Patient-Focused Research, LUNGevity Fou...
11 Aug 2022
Topics under discussion at the WCLC 2022 presidential symposium
Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
9 Aug 2022
Atezolizumab vs best supportive care in resected NSCLC
Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
9 Aug 2022
Working to improve global cancer care access in low middle-income countries
Dr Julie Gralow, Prof Eduardo Cazap
25 Jul 2022
ASCO Direct Highlights 2022: lung cancer highlights
Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA
9 Jul 2022
Locally and advanced immunotherapy developments and new agents in lung cancer
Dr George Simon - Moffitt Advent Health Clinical Research Unit, Tampa, USA
9 Jul 2022
Lung cancer immunotherapy adjuvant and neoadjuvant indications
Dr. Luis Raez - Memorial Healthcare System, Florida, USA
8 Jul 2022